Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RMD · against 84 other Healthcare companies of similar size
Ranked #10 of 85 · scores higher than 87% of peers
Bars: peers in each 10-point band of the profitability score24 peers with a profitability score of 90–100, including RMD · Click a bar to see the companies
Mainly thanks to its return on assets, operating margin and return on invested capital, which are stronger than most Healthcare peers.
| Metric | RMD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 82 reported | 25.8% | 12.5% | 80% | 33% | |
| Operating marginHigher is better · 83 reported | 33.4% | 19.3% | 90% | 33% | |
| Return on assetsHigher is better · 82 reported | 17.0% | 6.9% | 90% | 33% | |
| Return on equityHigher is better · 78 reported | 24.3% | 13.2% | 84% | Context only | |
| Gross marginHigher is better · 85 reported | 61.6% | 59.8% | 54% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 3 | 8.24T JPY (≈$56.0B) | 98 | 75 | |
| 3 | 23.8B USD | 98 | 84 | |
| 5 | 193.6B HKD (≈$24.8B) | 97 | 78 | |
| 5 | 18.5B USD | 97 | 62 | |
| 5 | 34.0B USD | 97 | 49 | |
| 10 | 225.2B CNY (≈$31.5B) | 96 | 63 | |
| 10 | 327.3B CNY (≈$45.8B) | 96 | 75 | |
| 10 | 32.8B USD | 96 | 69 | |
| 13 | 25.8B USD | 95 | 75 | |
| 13 | 34.3B USD | 95 | 57 | |
| 15 | 27.5B NZD (≈$16.5B) | 94 | 69 | |
| 16 | 67.60T KRW (≈$48.7B) | 93 | 72 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score